Difference between revisions of "Leuprolide (Lupron)"
m |
m |
||
| Line 17: | Line 17: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | *4/09/1985: Initial FDA approval for palliative treatment of advanced prostate cancer. | + | *4/09/1985: Initial FDA approval for palliative treatment of advanced [[Prostate cancer|prostate cancer]]. |
==Also known as== | ==Also known as== | ||
| Line 32: | Line 32: | ||
[[Category:Prostate cancer medications]] | [[Category:Prostate cancer medications]] | ||
[[Category:Drugs FDA approved in 1985]] | [[Category:Drugs FDA approved in 1985]] | ||
| + | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 18:54, 5 June 2016
General information
Class/mechanism: GnRH (gonadotropin-releasing hormone)/LHRH (luteinizing hormone releasing hormone) agonist; inhibits gonadotropin secretion, decreasing circulating levels of LH (luteinizing hormone) and FSH (follicle stimulating hormone), and suppressing synthesis of ovarian and testicular steroids.[1][2][3][4][5][6]
Route: IM
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Leuprolide (Lupron) patient drug information (Chemocare)[7]
- Brief patient counseling information can be found in the Leuprolide (Lupron) package insert[1]
- Brief patient counseling information can be found in the Leuprolide (Eligard) package insert[4]
- Leuprolide (Lupron) patient drug information (UpToDate)[8]
History of changes in FDA indication
- 4/09/1985: Initial FDA approval for palliative treatment of advanced prostate cancer.
Also known as
Eligard, leuprolide acetate, Lupron Depot, Leupromer, Leuprorelin, Prostap SR, Prostap 3, or Viadur.
References
- ↑ 1.0 1.1 1.2 Leuprolide (Lupron) package insert
- ↑ Leuprolide (Lupron) package insert (locally hosted backup)
- ↑ Lupron manufacturer's website
- ↑ 4.0 4.1 Leuprolide (Eligard) package insert
- ↑ Leuprolide (Eligard) package insert (locally hosted backup)
- ↑ Eligard manufacturer's website
- ↑ Leuprolide (Lupron) patient drug information (Chemocare)
- ↑ Leuprolide (Lupron) patient drug information (UpToDate)